BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7283686)

  • 21. Ehlers-Danlos syndromes and Marfan syndrome.
    Callewaert B; Malfait F; Loeys B; De Paepe A
    Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):165-89. PubMed ID: 18328988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Changes in the hand in Ehlers-Danlos syndrome type IV].
    Meinel A; Scharizer E
    Handchir Mikrochir Plast Chir; 1989 Mar; 21(2):103-6. PubMed ID: 2707649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations in the lysyl hydroxylase 1 gene that result in enzyme deficiency and the clinical phenotype of Ehlers-Danlos syndrome type VI.
    Yeowell HN; Walker LC
    Mol Genet Metab; 2000; 71(1-2):212-24. PubMed ID: 11001813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysphonia--a rare early symptom of Ehlers--Danlos syndrome?
    Rimmer J; Giddings CE; Cavalli L; Hartley BE
    Int J Pediatr Otorhinolaryngol; 2008 Dec; 72(12):1889-92. PubMed ID: 18976821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Vascular Ehlers-Danlos syndromes--biochemical and molecular-genetic investigations].
    Lund AM
    Ugeskr Laeger; 2006 Feb; 168(9):915-20. PubMed ID: 16513057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A connective tissue disorder may underlie ESSENCE problems in childhood.
    Baeza-Velasco C; Grahame R; Bravo JF
    Res Dev Disabil; 2017 Jan; 60():232-242. PubMed ID: 27802895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pain in ehlers-danlos syndrome is common, severe, and associated with functional impairment.
    Voermans NC; Knoop H; Bleijenberg G; van Engelen BG
    J Pain Symptom Manage; 2010 Sep; 40(3):370-8. PubMed ID: 20579833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of muscle hypotonia and weakness on balance: a study on Prader-Willi and Ehlers-Danlos syndrome patients.
    Galli M; Cimolin V; Vismara L; Grugni G; Camerota F; Celletti C; Albertini G; Rigoldi C; Capodaglio P
    Res Dev Disabil; 2011; 32(3):1117-21. PubMed ID: 21306869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chiropractic management of Ehlers-Danlos syndrome: a report of two cases.
    Colloca CJ; Polkinghorn BS
    J Manipulative Physiol Ther; 2003 Sep; 26(7):448-59. PubMed ID: 12975632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Peroneal nerve palsy in patient with Ehlers-Danlos syndrome].
    Al-Aubaidi Z; Skov O
    Ugeskr Laeger; 2011 Jan; 173(5):356-7. PubMed ID: 21276402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of skin extensibility and joint hypermobility in patients with spontaneous cervical artery dissection and Ehlers-Danlos syndrome.
    Heidbreder AE; Ringelstein EB; Dittrich R; Nabavi D; Metze D; Kuhlenbäumer G
    J Clin Neurosci; 2008 Jun; 15(6):650-3. PubMed ID: 18400501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypermobility, the Ehlers-Danlos syndromes and chronic pain.
    Syx D; De Wandele I; Rombaut L; Malfait F
    Clin Exp Rheumatol; 2017; 35 Suppl 107(5):116-122. PubMed ID: 28967365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Ehlers-Danlos syndrome--20 years experience with diagnosis and classification at the university skin clinic of Heidelberg].
    Proske S; Hartschuh W; Enk A; Hausser I
    J Dtsch Dermatol Ges; 2006 Apr; 4(4):308-18. PubMed ID: 16638060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subjective health complaints in individuals with Ehlers-Danlos syndrome: a questionnaire study.
    Maeland S; Assmus J; Berglund B
    Int J Nurs Stud; 2011 Jun; 48(6):720-4. PubMed ID: 21094943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychosocial functioning in the Ehlers-Danlos syndrome.
    Lumley MA; Jordan M; Rubenstein R; Tsipouras P; Evans MI
    Am J Med Genet; 1994 Nov; 53(2):149-52. PubMed ID: 7856639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ehlers-Danlos syndrome coexisting with juvenile nephronophtisis.
    Tarrass F; Benjelloun M; Hachim K; Benghanem MG; Ramdani B; Zaid D; Benkirane A; Sqalli S
    Nephrology (Carlton); 2006 Apr; 11(2):117-9. PubMed ID: 16669972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COL5A1 signal peptide mutations interfere with protein secretion and cause classic Ehlers-Danlos syndrome.
    Symoens S; Malfait F; Renard M; André J; Hausser I; Loeys B; Coucke P; De Paepe A
    Hum Mutat; 2009 Feb; 30(2):E395-403. PubMed ID: 18972565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ehlers-Danlos syndrome--diagnosis and subclassification].
    Rand-Hendriksen S; Wekre LL; Paus B
    Tidsskr Nor Laegeforen; 2006 Aug; 126(15):1903-7. PubMed ID: 16915311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multidisciplinary treatment of disability in ehlers-danlos syndrome hypermobility type/hypermobility syndrome: A pilot study using a combination of physical and cognitive-behavioral therapy on 12 women.
    Bathen T; Hångmann AB; Hoff M; Andersen LØ; Rand-Hendriksen S
    Am J Med Genet A; 2013 Dec; 161A(12):3005-11. PubMed ID: 23913726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular genetics in classic Ehlers-Danlos syndrome.
    Malfait F; De Paepe A
    Am J Med Genet C Semin Med Genet; 2005 Nov; 139C(1):17-23. PubMed ID: 16278879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.